CME Group Inc. (NASDAQ:CME) Director Martin J. Gepsman sold 200 shares of the business’s stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $126.14, for a total value of $25,228.00. Following the sale, the director now owns 43,311 shares in the company, valued at $5,463,249.54. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

CME Group Inc. (CME) traded down 0.44% during midday trading on Friday, reaching $123.64. The company’s stock had a trading volume of 271,946 shares. The firm has a market capitalization of $42.03 billion, a price-to-earnings ratio of 25.24 and a beta of 0.73. The stock’s 50-day moving average price is $123.43 and its 200-day moving average price is $120.91. CME Group Inc. has a 12 month low of $98.95 and a 12 month high of $127.96.

CME Group (NASDAQ:CME) last posted its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The company had revenue of $925 million for the quarter, compared to analyst estimates of $931.05 million. During the same period last year, the company earned $1.14 earnings per share. The business’s revenue was up 2.1% compared to the same quarter last year. Analysts predict that CME Group Inc. will post $4.81 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.64 annualized dividend and a yield of 2.13%. CME Group’s dividend payout ratio (DPR) is currently 53.99%.

TRADEMARK VIOLATION WARNING: This report was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another site, it was stolen and reposted in violation of US and international trademark & copyright law. The legal version of this report can be accessed at https://www.watchlistnews.com/martin-j-gepsman-sells-200-shares-of-cme-group-inc-cme-stock/1472873.html.

CME has been the subject of a number of analyst reports. Deutsche Bank AG cut their price target on CME Group from $137.00 to $134.00 and set a “buy” rating for the company in a report on Friday, April 28th. Jefferies Group LLC reiterated a “buy” rating and issued a $134.00 target price (up from $128.00) on shares of CME Group in a research note on Monday, July 17th. Royal Bank Of Canada dropped their target price on CME Group from $133.00 to $130.00 and set an “outperform” rating for the company in a research note on Monday, May 1st. Finally, BidaskClub upgraded CME Group from a “sell” rating to a “hold” rating in a research note on Thursday, August 3rd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the company. The company has an average rating of “Hold” and an average price target of $131.63.

A number of institutional investors have recently bought and sold shares of CME. Public Sector Pension investment Board increased its stake in shares of CME Group by 21.7% in the second quarter. Public Sector Pension investment Board now owns 93,810 shares of the financial services provider’s stock valued at $11,749,000 after buying an additional 16,700 shares in the last quarter. UBS Asset Management Americas Inc. increased its stake in shares of CME Group by 6.8% in the second quarter. UBS Asset Management Americas Inc. now owns 1,132,380 shares of the financial services provider’s stock valued at $141,819,000 after buying an additional 72,531 shares in the last quarter. Quantitative Investment Management LLC acquired a new stake in shares of CME Group during the second quarter valued at about $38,411,000. New York State Common Retirement Fund increased its stake in shares of CME Group by 1.2% in the second quarter. New York State Common Retirement Fund now owns 967,419 shares of the financial services provider’s stock valued at $121,160,000 after buying an additional 11,899 shares in the last quarter. Finally, Investec Asset Management PTY Ltd increased its stake in shares of CME Group by 48.6% in the second quarter. Investec Asset Management PTY Ltd now owns 11,921 shares of the financial services provider’s stock valued at $1,491,000 after buying an additional 3,898 shares in the last quarter. Institutional investors own 83.29% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.